Spago Nanomedical AB Financial Overview
Spago Nanomedical AB's market cap is currently €8.68M. The company's EPS TTM is €-0.001201577; its P/E ratio is -1.64; Spago Nanomedical AB is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.